Compass Wealth Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$329K Buy
+3,586
New +$314K 0.06% 146
2025
Q4
Sell
-3,221
Closed -$257K 88
2025
Q3
$257K Hold
3,221
0.06% 139
2025
Q2
$293K Buy
3,221
+8
+0.2% +$730 0.07% 134
2025
Q1
$301K Hold
3,213
0.08% 130
2024
Q4
$292K Hold
3,213
0.07% 136
2024
Q3
$334K Hold
3,213
0.08% 135
2024
Q2
$312K Hold
3,213
0.08% 134
2024
Q1
$289K Hold
3,213
0.07% 137
2023
Q4
$256K Hold
3,213
0.07% 139
2023
Q3
$228K Hold
3,213
0.07% 148
2023
Q2
$248K Hold
3,213
0.07% 146
2023
Q1
$241K Hold
3,213
0.08% 146
2022
Q4
$253K Buy
+3,213
New +$241K 0.08% 141

Other funds holding CL

Compass Wealth Management's CL Position: Q2 2026 in Review

Compass Wealth Management opened a new position in Colgate-Palmolive (CL) in Q2 2026: 3,586 shares worth $329K. The stake represents 0.06% of the portfolio and ranks #146 among its holdings. This is a return to the name: Compass Wealth Management previously reported a position in CL as recently as Q3 2025.

Compass Wealth Management first reported a position in CL in Q4 2022 and has held it in 13 quarters since. The position peaked at $334K in Q3 2024. 2,016 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Compass Wealth Management held 3,586 shares of Colgate-Palmolive worth $329K as of Q2 2026.
  • Colgate-Palmolive was a new Compass Wealth Management position in Q2 2026.
  • Colgate-Palmolive made up 0.06% of Compass Wealth Management's portfolio in Q2 2026, its #146 holding.
  • Compass Wealth Management first reported a position in Colgate-Palmolive in Q4 2022 and has held it in 13 quarters since.
  • Compass Wealth Management's Colgate-Palmolive position peaked at $334K in Q3 2024.
  • 2,016 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Compass Wealth Management's 13F filing for Q2 2026, filed 10 Aug 2026.